We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
A new world is possible. Let's not go back to what wasn't working anyway.
Add this topic to your myFT Digest for news straight to your inbox
More testing, faster booster rollout and compulsory mask-wearing introduced as virus spreads in Europe
If governments refuse to co-operate, we are left with the horror of children drowning on our shores
Growing evidence that Omicron has spread to Europe
Swiss effort to control spread of Omicron variant means face to face talks on improving access to vaccine are postponed
Strong spirits demand and vaccine vial competition prompt search for new vessels
Black Friday and Cyber Monday take the headlines, but Giving Tuesday is chance to make a real difference for others and ourselves
Era of grand celebrations appears over as companies opt for smaller gatherings amid fears of infection
Higher prices and more stingy discounts propel billions in sales at start of holiday season
Discovery of mutated virus abruptly pulls Covid back on to market radar
Uncertainty over patient numbers leaves health leaders reluctant to overpromise
Decision over heavily mutated strain comes as more countries tighten travel from southern Africa
Almost £5bn of fraud estimated in relation to state-backed bounceback programme
Brent and WTI crude grades record biggest one-day losses since April 2020
Pharma groups run lab tests after WHO raises alarm about strain with worrying array of mutations
Stocks slide and countries impose travel bans after discovery of new Covid variant
Scientists fear emerging strain could be more transmissible and have higher resistance to vaccines
Director Ridley Scott is wrong to castigate the under-40s fiddling with their phones for a film that flops
Prospect of return to widespread curbs on international flights revives concerns for sector
Scientists say they are being punished for transparency over their discovery of new variant
Markets are fragile and set to be highly volatile in 2022
Constant juggling between home and work life is dreadful, but occasional flexibility is necessary
Investors are taking into consideration that strict restrictions will return
Full analysis of trial results shows molnupiravir had a risk reduction of 30%
UK warns B.1.1.529 strain ‘may be more transmissible’ than Delta and vaccines ‘may be less effective’
International Edition
